Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressor

1 Apr 2017

Abstract excerpt

The majority of cancer-related deaths are caused by tumor recurrence, metastasis and therapeutic resistance. During the late stages of tumor progression, multiple factors are involved, including the downregulation and/or loss of function of metastasis suppressors. Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, was initially identified as a putative tumor suppressor that is frequently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Caveolin-1 and cellular processes
Share to Cell Adhesion Molecules Research
Share to Cellular Mechanics and Interactions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30258911
DOI: 10.1016/j.gendis.2017.03.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epithelial protein lost in neoplasm (EPLIN): Beyond a tumor suppressorPMID 30258911Read ↗

Epithelial Protein Lost in Neoplasm, EPLIN, the Cellular and Molecular Prospects in CancersSemantic proximity Read ↗

EPLIN: a fundamental actin regulator in cancer metastasis?Semantic proximity Read ↗

Update on Epithelial-Mesenchymal Plasticity in Cancer ProgressionSemantic proximity Read ↗

Epithelial–mesenchymal plasticity in cancer: signaling pathways and therapeutic targetsSemantic proximity Read ↗

Characterization of the human EPLIN (Epithelial Protein Lost in Neoplasm) gene reveals distinct promoters for the two EPLIN isoformsSemantic proximity Read ↗

Mechanistic insights of epithelial protein lost in neoplasm in prostate cancer metastasisSemantic proximity Read ↗

Revisiting the Roles of Pro-Metastatic EpCAM in CancerSemantic proximity Read ↗

Understanding the versatile roles and applications of EpCAM in cancers: from bench to bedsideSemantic proximity Read ↗

Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal TransitionSemantic proximity Read ↗

Characterization of LIMA1 and its emerging roles and potential therapeutic prospects in cancersSemantic proximity Read ↗

Inhibition of anchorage-independent growth of transformed NIH3T3 cells by epithelial protein lost in neoplasm (EPLIN) requires localization of EPLIN to actin cytoskeleton.Semantic proximity Read ↗

Molecular regulation of epithelial-to-mesenchymal transition in tumorigenesis (Review)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.